Abiopharma

🔍 Smith Darrin (Executive)

Company: Sabra Health Care REIT, Inc. (SBRA)

Report Date: 2026-08-31

Detailed Transactions and Holdings:

• Acquired 495 shares of Common Stock (Direct)
  Date: 2026-08-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 116,919.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.
• F2: Includes 34,182 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.